ABBOTT RECEIVES FDA APPROVAL FOR ITS TACTIFLEX™ DUO ABLATION CATHETER TO TREAT PEOPLE WITH ABNORMAL HEART RHYTHMS || TO BEGIN BROADER COMMERCIAL ADOPTION OF TACTIFLEX DUO IN US IN COMING WEEKS 08-SEP-2026 08:03 AM ET